Published in Biotech Business Week, January 3rd, 2005
The diagnostic test is intended to be used as an aid in the assessment and evaluation of patients suspected of having thromboembolic events, including pulmonary embolism. Pulmonary embolism, or PE, is a blockage of one or more of the pulmonary arteries by blood clot, which is a common and highly lethal condition that is a leading cause of death in all age groups.
Portable and easy-to-use, this point-of-care diagnostic test can be used in the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.